Hotline 24/7: 0909384389

Share links:

CeloNova completes enrolment in first 14-day DAPT randomised controlled trial

Ngày 03/06/2020 09:05 | Lượt xem: 943

CeloNova BioSciences has announced that it has successfully completed enrolment into the COBRA REDUCE randomised controlled trial to evaluate the safety and efficacy of the Cobra PzF nanocoated coronary stent (NCS) in percutaneous coronary intervention (PCI) with 14-day dual antiplatelet therapy (DAPT). The study will compare it to US Food and Drug Administration (FDA)-approved drug-eluting stents (DES) with three or six months DAPT in 996 patients at high bleeding risk across 60 global sites.

A press release from CeloNova states that the Cobra PzF NCS is nanocoated with Polyzene-F, a surface coating that acts as a barrier between the device, intimal surface, and circulating elements in the blood. It has demonstrated anti-inflammatory and thromboresistant properties, and significantly faster, higher quality healing compared to market-leading DES in preclinical studies.

The statement from the company points out that COBRA REDUCE is the world’s first and only study to evaluate 14-day DAPT in high bleeding risk patients. All enrolled patients are on oral anticoagulation therapy. Many patients also share a second major or minor bleeding criteria, such as recent ischaemic stroke, cancer, anaemia, or severe or end-stage chronic kidney disease. 

Robert A Byrne (Royal College of Surgeons in Ireland [RSCI] University of Health Sciences, Dublin, Ireland) is coprincipal investigator of the trial, which is being coordinated by the ISAR Research Center in Munich, Germany. He says in the press release: “The outcome of the COBRA REDUCE trial represents a potentially game-changing approach to treating high bleeding risk patients. Physicians are still in need of a safe and effective treatment option for their most urgent or non-compliant patients who are at high bleeding risk. Data from this study evaluating COBRA PzF NCS with 14-day DAPT will provide valuable information on treatment options for this underserved patient population.” 

“The bleeding risk of a PCI patient increases considerably when you factor in major criteria such as use of oral anticoagulants, recent stroke, or undeferrable surgery post-PCI. Unfortunately, these patients and others are excluded from participating in clinical studies due to their higher risk profile,” says Carl St Bernard, president and chief executive officer of CeloNova. “COBRA REDUCE’s rigorous and randomised approach is designed to assess such ‘worst-case’ clinical bleeding scenarios and the impact of significantly fewer medications with COBRA PzF NCS compared to market-leading DES.”

Source CardiovascularNews

Duc Tin Clinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support